Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.70107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Yuxin Nong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Pro…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Antioxidants, Human Umbilical Vein Endothelial Cells, Chalcones. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (grant No. Y0120220151), National Natural Science Foundati….
Abstract (Originalsprache)
Background
Endothelial dysfunction is one of the important mechanisms of organ and tissue damage in sepsis. In this study, we evaluated the effects of neohesperidin dihydrochalone (NHDC) on lipopolysaccharide (LPS)‐induced vascular dysfunction and explored the potential mechanisms.
Methods
In vivo, we assessed vascular leakage in mice by injecting Evans blue dye. In vitro, cell counting kit‐8 (CCK‐8) assay and flow cytometry were used to assess the activity of HUVEC and apoptosis. The effect of LPS on HUVEC barrier was assessed using FITC‐extend membrane assay. The adhesion ability of HUVEC was tested by THP‐1 cell adhesion assay. The antioxidant capacity of cells was measured by detecting the level of mitochondrial membrane potential, ROS, and content of CAT, SOD, GSH, and MDA within the cells. Furthermore, the release of endothelial IL‐1β, IL‐6, and TNF‐α were detected by ELISA, and the expression level of TAK1, ERK1/2, and NFκB were detected by western blot.
Results
Treatment with NHDC effectively alleviated LPS‐induced endothelial permeability and organ damage by reducing reactive oxygen species production and enhancing the antioxidant response. Further investigation suggested that NHDC may exert its protective effects by inhibiting the release of IL‐1β, IL‐6, and TNF‐α, and by decreasing the phosphorylation of key inflammatory signaling molecules, including transforming growth factor‐β‐activated kinase 1 (TAK1), extracellular signal‐regulated kinases 1/2 (ERK1/2), and nuclear factor kappa B (NFκB).
Conclusions
Our study indicate that pretreatment with NHDC may provide protection against LPS‐induced vascular dysfunction by reducing oxidative stress and activation of inflammatory signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guan…
- Shantou University Medical College, Shantou, China.
- Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
ORCID-Profile: Yuxin Nong, Junquan Lu, Danqing Yu, Xuebiao Wei
Förderung
- This study was supported by Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention (grant No. Y0120220151), National Natural Science Foundati…
Zitieren
APA
Nong, Y., Lu, J., Yu, D., & Wei, X. (2024). Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70107
Vancouver
Nong Y, Lu J, Yu D, Wei X. Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70107
BibTeX
@article{Nong2024,
author = {Nong, Yuxin and Lu, Junquan and Yu, Danqing and Wei, Xuebiao},
title = {Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.70107}
}
EUVIMED